Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
16.76
0.00 (0.00%)
May 20 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 9.91 - 19.46
Open     -
Vol / Avg. 0.00/885,662.00
Mkt cap 2.80B
P/E 41.41
Div/yield     -
EPS 0.40
Shares 167.07M
Beta 1.51
Inst. own 60%
Jun 13, 2013
Bruker Corporation at Goldman Sachs Healthcare Conference Add to calendar
Jun 12, 2013
Bruker Corporation at William Blair Growth Stock Conference Add to calendar
Jun 3, 2013
Bruker Corporation at Jefferies Global Healthcare Conference Add to calendar
May 29, 2013
Bruker Corporation at Deutsche Bank Health Care Conference Add to calendar
May 20, 2013
Bruker Corporation at UBS Global Healthcare Conference
May 16, 2013
Bruker Corporation Annual Shareholder Meeting
May 14, 2013
Bruker Corporation at Bank of America Merrill Lynch Health Care Conference
May 2, 2013
Q1 2013 Bruker Corporation Earnings Conference Call - Webcast
Apr 29, 2013
Q1 2013 Bruker Corporation Earnings Release
Mar 12, 2013
Bruker Corporation at Barclays Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 1.45% 4.37%
Operating margin 3.10% 8.71%
EBITD margin - 13.47%
Return on average assets 1.25% 4.38%
Return on average equity 3.10% 11.67%
Employees 6,000 -
Carbon Disclosure Rating - -

Address

40 Manning Road
BILLERICA, MA 1821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Bruker Corporation (Bruker) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The Company�s technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. Its manufacture and distribute a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosives, or CBRNE, detection. In April 2012, it acquired SkyScan N.V.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Charles F. Wagner Jr. Chief Financial Officer, Executive Vice President
Bio & Compensation  - Reuters
Mark R. Munch Ph.D. President of Bruker Nano, Inc
Age: 50
Bio & Compensation  - Reuters
Burkhard Prause Ph.d. President and Chief Executive Officer of Bruker Energy & Supercon Technologies, Inc
Age: 45
Bio & Compensation  - Reuters
Stephan Westermann EVP-Order Execution, Production & Logistics, BSI Segment & EVP -Operations, Bruker BioSpin Group
Age: 44
Bio & Compensation  - Reuters
Anthony L. Mattacchione Senior Vice President - Corporate Finance and Accounting
Age: 49
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 35
Bio & Compensation  - Reuters
Richard M. Stein Secretary, Director
Age: 60
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 64
Bio & Compensation  - Reuters
Marc Kastner Director
Bio & Compensation  - Reuters